Table 5. Results of sex differences in postoperative pain outcome and subgroup analysis focusing on the influence of age and preoperative pain.
Outcome | Sex | All Groups | Age Groups | Preoperative Pain Groups | ||
---|---|---|---|---|---|---|
<50 years | ≥50 years | with | without | |||
Worst pain since surgery | Women | 5.75 ± 2.61* | 5.85 ± 2.59 | 5.68 ± 2.85* | 5.97 ± 2.72* | 5.24 ± 2.71 |
Men | 5.20 ± 2.70 | 5.58 ± 2.61 | 4.72 ± 2.73 | 5.50 ± 2.60 | 4.89 ± 2.78 | |
Time spent in severe pain | Women | 34% ± 25%* | 34% ± 24%* | 34% ± 26%* | 37% ± 26%* | 27% ± 23% |
Men | 27% ± 23% | 27% ± 23% | 26% ± 22% | 29% ± 23% | 24% ± 22% | |
Interference of pain with in-bed activities | Women | 4.65 ± 2.83 | 4.68 ± 2.83 | 4.64 ± 2.83* | 4.97 ± 2.71 | 3.92 ± 2.98 |
Men | 4.38 ± 2.83 |
4.81 ± 2.82 | 3.85 ± 2.76 |
4.75 ± 2.73 | 3.98 ± 2.91 |
|
Feeling anxious due to pain | Women | 2.66 ± 2.53* | 2.69 ± 2.49 | 2.65 ± 2.57* | 2.98 ± 2.60 | 1.90 ± 2.17 |
Men | 2.18 ± 2.39 | 2.30 ± 2.44 | 2.04 ± 2.33 | 2.58 ± 2.46 | 1.73 ± 2.22 | |
Feeling helpless due to pain | Women | 3.13 ± 3.05* | 3.01 ± 2.95* | 3.24 ± 3.14* | 3.59 ± 3.20* | 2.12 ± 2.44 |
Men | 2.31 ± 2.66 | 2.37 ± 2.69 | 2.23 ± 2.63 | 2.74 ± 2.78 | 1.81 ± 2.43 | |
Cumulative opioid consumption(mg/kg) | Women | 0.39 ± 0.50* | 0.39 ± 0.48 | 0.39 ± 0.51* | 0.45 ± 0.55* | 0.25 ± 0.34 |
Men | 0.31 ± 0.41 | 0.36 ± 0.44 | 0.24 ± 0.37 | 0.32 ± 0.42 | 0.30 ± 0.41 | |
Relief from pain | Women | 62% ± 26% | 66% ± 24%* | 59% ± 27%* | 59% ± 26% | 69% ± 26% |
Men | 62% ± 28% | 60% ± 28% | 64% ± 27% | 59% ± 27% | 64% ± 28% | |
Wish for more treatment was “Yes” | Women | 19% (72/388) | 22% (37/169) | 16% (35/218) | 22% (58/267) | 11% (13/117) |
Men | 17% (80/471) | 19% (48/260) | 15% (32/211) | 20% (49/244) | 14% (31/225) | |
Satisfaction with pain treatment | Women | 7.62 ± 2.75 | 7.62 ± 2.60 | 7.60 ± 2.88 | 7.49 ± 2.77 | 7.96 ± 2.69 |
Men | 7.53 ± 2.79 | 7.47 ± 2.61 | 7.61 ± 3.01 | 7.34 ± 2.93 | 7.74 ± 2.62 |
Results are presented as mean (± standard deviation) or relative numbers (% (n/N)). Groups were compared using Mann-Whitney U Test or χ2 Test (“wish for more treatment”).
* P<0.05 women vs. men